2020
DOI: 10.1186/s12944-020-01275-x
|View full text |Cite
|
Sign up to set email alerts
|

Low-density lipoprotein cholesterol lowering treatment: the current approach

Abstract: In the last 50 years, several clinical and epidemiological studies during have shown that increased levels of lowdensity lipoprotein cholesterol (LDLc) are associated with the development and progression of atherosclerotic lesions. The discovery of β-Hydroxy β-methylglutaryl-CoA reductase inhibitors (statins), that possess LDLc-lowering effects, lead to a true revolution in the prevention and treatment of cardiovascular diseases. Statins remain the cornerstone of LDLc-lowering therapy. Lipid-lowering drugs, su… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
48
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 55 publications
(49 citation statements)
references
References 52 publications
1
48
0
Order By: Relevance
“…Statins, inhibitors of 3-hydroxy-3methyl-glutaryl-CoA (HMG-CoA) reductase, decrease the cholesterol content of cells in experimental and clinical settings, and they have also been reported to decrease the dipole potential of the plasma membrane (32,34). Statins are the most commonly used therapeutic agents to treat hypercholesterolemia due to their beneficial effect on cardiovascular morbidity and mortality (35)(36)(37)(38). Although adverse effects, e.g.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Statins, inhibitors of 3-hydroxy-3methyl-glutaryl-CoA (HMG-CoA) reductase, decrease the cholesterol content of cells in experimental and clinical settings, and they have also been reported to decrease the dipole potential of the plasma membrane (32,34). Statins are the most commonly used therapeutic agents to treat hypercholesterolemia due to their beneficial effect on cardiovascular morbidity and mortality (35)(36)(37)(38). Although adverse effects, e.g.…”
Section: Introductionmentioning
confidence: 99%
“…Although adverse effects, e.g. myopathy, liver dysfunction and type 2 diabetes, have been associated with statins, they are usually well tolerated and successfully used even in combination with other drugs such as cholesterol absorption inhibitors or fibrates (38)(39)(40)(41). While the primary mechanism of action of all statins is identical, there are significant differences in their efficacy and bioavailability (40).…”
Section: Introductionmentioning
confidence: 99%
“…The risk of myopathy rises because of muscle atrophy associated with advanced age. By reducing the distribution volume, similar effects can be obtained, albeit with a smaller dose [ 110 , 111 ]. Treatment costs for the elderly.…”
Section: Statin Treatment In Postmenopausal Womenmentioning
confidence: 99%
“…Some unsaturated fatty acids have vital therapeutic properties and benefits for the body. Omega-3 fatty acids lower cholesterol and fat levels in the bloodstream and “cleanse” the blood vessels lining [ 120 ]. The use of ω-3 fatty acids as a remedy for heart disease, coronary disease, inflammation, rheumatoid arthritis and immunodeficiency diseases has been revealed by some research [ 97 , 121 ].…”
Section: Algae As Nutraceuticalsmentioning
confidence: 99%